Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2025-12-24 @ 3:02 PM
NCT ID:
NCT00385359
Eligibility Criteria:
Inclusion Criteria:
* Male or female aged 18-60 years
* Moderate asthma with baseline FEV1 40-75% predicted
* Previous use of albuterol (salbutamol)
* At least 20% improvement in FEV1 following 2.5 mg albuterol (salbutamol) delivered by nebulizer
* O2 saturation \> 90%
* Non-smoker for \> 6 months
Exclusion Criteria:
* Upper respiratory tract infection or asthma exacerbation within 14 days of screening
* Clinically significant abnormal chest radiograph
* History of cardiovascular disorder including coronary insufficiency, cardiac arrhythmias or hypertension
* Unable to tolerate bronchodilator withdrawal
* Known hypersensitivity to albuterol (salbutamol)
* Change in asthma treatment regimen in past 30 days
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00385359
Study Brief:
Protocol Section:
NCT00385359